Scopolamine augments transient auditory 40-hz magnetic response in humans

Neurosci Lett. 1999 Dec 24;277(2):115-8. doi: 10.1016/s0304-3940(99)00854-x.

Abstract

The influence of neocortical muscarinic transmission on auditory-evoked 40-Hz magnetic response was studied in 13 healthy subjects in a double-blind randomized cross-over design. Either a centrally (scopolamine hydrobromide, 0.3 mg, i.v.) or a peripherally (glycopyrrolate, 0.2 mg, i.v.) acting antagonist of muscarinic transmission was administered during two sessions of magnetoencephalographic recording of 40-Hz response elicited by monaural tones. Scopolamine significantly (P < 0.01) augmented the 40-Hz magnetic response over the hemispheres ipsi- and contralateral to the ear stimulated. This finding suggests muscarinic modulation of the auditory evoked transient 40-Hz response.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analysis of Variance
  • Cross-Over Studies
  • Double-Blind Method
  • Evoked Potentials, Auditory / drug effects*
  • Female
  • Glycopyrrolate / pharmacology*
  • Humans
  • Magnetoencephalography / drug effects*
  • Male
  • Muscarinic Antagonists / pharmacology*
  • Scopolamine / pharmacology*

Substances

  • Muscarinic Antagonists
  • Scopolamine
  • Glycopyrrolate